Vascular Biogenics Ltd. - Ordinary Shares (VBLT) Social Stream
Vascular Biogenics Ltd (VBLT) Price Targets From Analysts
Use the tables below to see what analysts covering Vascular Biogenics Ltd think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 48 weeks, VBLT's average price target has gone up $0.88.
Over the past 50 weeks, VBLT's average upside potential has been 164.18%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VBLT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
VBLT's average broker recommendation rating improved by 0.6 over the prior 26 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how Vascular Biogenics Ltd fares relative to all US stocks, note that its average analyst price target is greater than 3.73% of that group.
- VBLT has a greater number of analysts covering the stock than 22.98% of Pharmaceutical Products stocks.
- VBLT has a lower variance in analysts' estimates than 28.52% of stocks in the micro market cap category.
- In the context of Healthcare stocks, Vascular Biogenics Ltd's upside potential (average analyst target price relative to current price) is higher than 67.21% of them.
In the Pharmaceutical Products industry, UPC, TRVI, and TMBR are the three stocks most similar to Vascular Biogenics Ltd regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding VBLT using the data that counts. Try POWR Ratings for free.